Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Sales (2016 - 2026)

Biomerica's Return on Sales history spans 17 years, with the latest figure at 0.01% for Q1 2026.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.01% in Q1 2026 year-over-year; TTM through Feb 2026 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Sales hit 0.01% in Q1 2026 for Biomerica, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for BMRA hit a ceiling of 0.0% in Q3 2025 and a floor of 0.02% in Q2 2025.
  • Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
  • The widest YoY moves for Return on Sales: up 1bps in 2022, down -1bps in 2022.
  • Tracing BMRA's Return on Sales over 5 years: stood at 0.01% in 2022, then increased by 12bps to 0.01% in 2023, then soared by 40bps to 0.01% in 2024, then plummeted by -88bps to 0.01% in 2025, then dropped by -22bps to 0.01% in 2026.
  • Business Quant data shows Return on Sales for BMRA at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.